Navigation Links
Watson Acquires Ascent Pharmahealth for AU$375 Million
Date:1/23/2012

cts this entity to manage the Ascent assets.

Under the terms of the agreement, Watson acquired Ascent Pharmahealth for AU$375 million (approximately $393 million US) in cash. Watson funded the transaction using cash-on-hand and borrowings from its revolving credit facility. The deal is expected to be immediately accretive to 2012 non-GAAP earnings. The transaction was signed and closed simultaneously.

Watson will discuss the acquisition in more detail during its 2012 Investor Meeting in New York City on January 24, 2012.  The meeting will begin at 8:00 a.m. Eastern Time and will be simultaneously webcast. The webcast will be available live to investors and the media on Watson's Web site or at the following link: http://www.videonewswire.com/event.asp?id=84459.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets. 

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

About AscentAscent Pharmahealth Ltd, previously part of Strides Arcolab Ltd, services markets in Australia, Singapore, Malaysia, Hong Kong, Vietnam, Thailand and other Asian countries with a range of generic pharmaceuticals, consumer skincare and over the-counter (OTC) medicines. Ascent has a regional manufacturing facility located in Singapore which manufactures prescription and OTC products in varied dosage forms for the Southeast Asia market. 
Ascent is one of Australia's leading suppliers of healthcare products to pharmacies a
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Watson to Present at the 30th Annual J.P. Morgan Healthcare Conference
2. Watson to Present at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top
3. Watson Launches Generic LoSEASONIQUE(R)
4. Watson Launches Generic LIPITOR®
5. Watson to Present at the 2011 Piper Jaffray Health Care Conference
6. Watson Wins Kentucky Drug Pricing Litigation
7. Watson Confirms Exelon(R) Patent Challenge
8. Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA
9. Watson Third Quarter 2011 Net Revenue Climbs 23% to $1.1 Billion; Non-GAAP Diluted EPS of $1.09; GAAP Diluted EPS of $0.54
10. Watson Confirms Court Grants Preliminary Injunction Preventing Launch of Generic LOVENOX®
11. Watson to Present at the 2011 Annual Credit Suisse Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... FARMINGTON, Conn. , Dec. 24, 2014 /PRNewswire/ ... biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for ... need and commercial potential, today announced that it ... shares of its common stock and Series C ... stock.  Funds under the management of QVT Financial ...
(Date:12/24/2014)... SAN DIEGO , Dec. 23, 2014 ResMed ... a significant patent infringement action against Chinese medical device manufacturer ... Commission (ITC) ruled today that BMC,s masks listed below infringe ... advertising, or selling these masks in the United ... , iVolve N2 nasal mask , Willow nasal pillows ...
(Date:12/24/2014)...  The American Diabetes Association is recommending a ... with diabetes and that all people with diabetes ... in keeping with recent changes to guidelines for ... of Cardiology (ACC) and American Heart Association (AHA). ... changes to the Association,s annual revised Standards of ...
Breaking Medicine Technology:Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4
... , June 16 TechniScan, (OTC Bulletin Board: TSNI) a ... 3D breast ultrasound imaging system, today announced that it has launched a ... to commence in the last five months. , ... TechniScan,s Warm Bath Ultrasound (WBU) system is designed to ...
... Concerned About Drugs, Role in Crisis of Prematurity , ... WHITE PLAINS, N.Y. , June 16 The widespread use of fertility ...  contributes to the problem of premature birth in the United States , experts said ... , , ...
Cached Medicine Technology:TechniScan Announces Adding Another Center to Worldwide Clinical Trials for New Breast Imaging System 2TechniScan Announces Adding Another Center to Worldwide Clinical Trials for New Breast Imaging System 3TechniScan Announces Adding Another Center to Worldwide Clinical Trials for New Breast Imaging System 4TechniScan Announces Adding Another Center to Worldwide Clinical Trials for New Breast Imaging System 5Fertility Drugs Contribute Heavily to Multiple Births 2Fertility Drugs Contribute Heavily to Multiple Births 3
(Date:12/26/2014)... 26, 2014 “Many people become overwhelmed ... injury claim issues and phone calls with insurance companies,” ... article featuring their free eBook on pedestrian and ... on pedestrian and bicycle auto accident claims assures the ... capable of professionally handling their case while they focus ...
(Date:12/26/2014)... Pentec Health, Inc. number fourteen on ... Pennsylvania for 2014. The awards program, created in 2000, ... kind in the country. The program is a public/private ... Community and Economic Development, the Pennsylvania State Council of ... Penn Business Journal. , Charlie Wilson, Vice ...
(Date:12/26/2014)... AZ (PRWEB) December 26, 2014 ... source for the best in heating, cooling and ... for 24 hour emergency services in 2014 with ... alike know that Arizona is known for its ... company that understands the intricacies and details of ...
(Date:12/25/2014)... This is a professional and in-depth ... industry with a focus on the Chinese market. The ... the Sterilizers manufacturers and is a valuable source of ... the industry. This report provides a basic overview of ... In this part, the report presents the company profile, ...
(Date:12/25/2014)... The report “Nintedanib (Colorectal Cancer) ... on the current treatment landscape, unmet needs, current ... market. Stivarga is a drug which is used ... Boehringer Ingelheim is developing nintedanib (BIBF-1120), an orally ... CRC in the US, Europe, and Japan. The ...
Breaking Medicine News(10 mins):Health News:Guide to Handling Pedestrian and Bicycle Accidents Released By The Jones Firm, Featured in Recent Article 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4
... Montreal, March 23, 2010 Obtaining therapy via teleconference ... a new research by Stphane Guay, a psychiatry professor ... have shown that phobia therapy via teleconferencing was just ... Guay, who is also director of the Trauma Studies ...
... been sought by people wanting to ward off the signs ... than tightening loose skin to restore a youthful look. A ... indicates that significant changes in facial bones particularly the ... an aging appearance. Presented today at the American ...
... ... Robert Ladenburger Join Not-For-Profit Catholic Health System Board, , ... Novi, Michigan (Vocus) March 23, 2010 -- ... Board of Directors. The new members are Paul Robertson, Chairman and CEO of Robertson ...
... that replacing saturated fats has heart benefits , ... with polyunsaturated fats may reduce your risk of heart ... Health researchers reviewed eight studies with a total of ... fats in their diet with polyunsaturated fats had a ...
... ... the treatment of acute injuries and chronic conditions affecting soft tissues, such as tendons ... ... a leading provider of physical medicine and rehabilitation services in the metropolitan New York ...
... Bailes , MD, BHR Pharma, LLC,s Lead Advisor for Moderate Traumatic Brain Injury (TBI) today released the following statement regarding Brain Injury Awareness Month: , ... , ... ... ...
Cached Medicine News:Health News:Therapy via teleconference? 2Health News:Facial aging is more than skin deep 2Health News:Trinity Health Appoints Four to Board of Directors,Trinity Health Appoints Four to Board of Directors, 2Health News:Trinity Health Appoints Four to Board of Directors,Trinity Health Appoints Four to Board of Directors, 3Health News:Polyunsaturated Fats Really May Lower Heart Risk 2Health News:New York Sports Medicine Offers Platelet Rich Plasma Therapy For Treatment of Injury 2Health News:New York Sports Medicine Offers Platelet Rich Plasma Therapy For Treatment of Injury 3Health News:BHR Pharma Statement on Brain Injury Awareness Month - Better Awareness, Treatment, Research Needed Now 2Health News:BHR Pharma Statement on Brain Injury Awareness Month - Better Awareness, Treatment, Research Needed Now 3
... for the screening of factor-V-related APC resistance. ... test for the factor V:Q506 mutation is ... an excess of V-DEF Plasma bioreagent. The ... between heterozygous and homozygous factor V genotypes. ...
Inquire...
Inquire...
... remarkable anti-reflux valve is enclosed ... which prevents the valve from ... in sitting or reclining positions. ... and interference free ensuring uninterrupted ...
Medicine Products: